Chemocentryx Inc. (CCXI)

Trade CCXI now with
3/8/2021 8:35:17 AM ChemoCentryx Appoints Susan Kanaya To Board
2/24/2021 8:37:57 AM ChemoCentryx Appoints Tausif Butt As EVP And COO
7/9/2020 8:41:51 AM ChemoCentryx Submits NDA For Avacopan In ANCA-Associated Vasculitis
6/3/2020 7:34:19 AM ChemoCentryx Announces Presentations Highlighting Outcomes Of Phase III ADVOCATE Trial
5/18/2020 8:47:52 AM ChemoCentryx,VFMCRP Report Topline Data From Phase II LUMINA-1 Trial Of CCX140
1/9/2020 8:40:52 AM ChemoCentryx Secures Credit Facility Of Up To $100 Mln Provided By Hercules Capital
1/24/2019 8:41:52 AM ChemoCentryx Reports Withdrawal Of Phase II-Based CMA Application For ANCA-Associated Vasculitis In Europe
9/27/2018 10:35:16 PM ChemoCentryx Says Not To Proceed With Public Offering
9/26/2018 4:09:07 PM ChemoCentryx Announces Proposed Public Offering Of Common Stock
3/9/2018 7:16:36 AM ChemoCentryx Q4 Net Income $39.7 Mln Vs Net Loss $7.7 Mln Last Year
1/8/2018 8:37:31 AM ChemoCentryx Appoints William Fairey As EVP And COO
1/4/2018 7:04:14 AM ChemoCentryx To Receive Regulatory Milestone Payment From VFMCRP